Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl



Institución Fundación Arturo López Pérez

Publicaciones

Citas Totales

Instituciones en Colaboración

×

¿Quieres unificar este perfil a otros que correspondan al mismo autor? Recuerda, la unificación de perfiles permite fusionar las publicaciones, asociadas a distintas firmas, en una única firma llamada "base".
Esta operación no elimina las firmas de autor originales de una publicación. Tampoco altera otras bases de datos que no sean DataCiencia.

  • Paso 1: Pincha el botón de "Unificar Perfiles"
    • - Verás un listado de firmas en las cuales coincide el primer apellido y la primera letra del nombre. Costado izquierdo de la pantalla ("Sugerencias").
    • - Ese listado está acompañado de información sobre algunas publicaciones y afiliaciones.
  • Paso 2: Selecciona una firma como "Base". Escoge aquella firma más completa.
    • - Esta firma agrupará las publicaciones de las otras firmas.
    • - Por defecto, la primera firma del listado es la que contiene más publicaciones.
  • Paso 3: Selecciona una o varias firmas como "Agrupar".
    • - Las publicaciones y afiliaciones de estas firmas se añadirán a la firma base.
  • Paso 4: Ingresa tu correo electrónico.
    • - Este es un método de validación obligatorio.
    • - Solo una solicitud por correo electrónico.
  • Paso 5: Pincha el botón "Enviar solicitud".
    • - Recibirás un correo por tu solicitud la cual estará pendiente de evaluación.
    • - Recibirás un segundo correo cuando tu solicitud sea procesada de forma completa, parcial, o rechazada.


Continuar

* ¿Por qué es necesario unificar perfiles? Muchas veces las publicaciones vienen desde el origen (WoS, Scopus o SciELO) vinculadas a distintas firmas de autor a pesar de corresponder a las mismas personas.


Disciplinas de Investigación





Muestra la distribución de su producción desde 2008 por disciplinas.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

WOS #Pub
Oncology 37
Medicine, General & Internal 25
Radiology, Nuclear Medicine & Medical Imaging 16
Urology & Nephrology 11
Hematology 8
Infectious Diseases 6
Obstetrics & Gynecology 4
Medicine, Research & Experimental 4
Multidisciplinary Sciences 4
Respiratory System 4
Health Care Sciences & Services 3
Dermatology 3
Surgery 3
Cell Biology 2
Pharmacology & Pharmacy 2
Pathology 2
Biology 2
Health Policy & Services 2
Materials Science, Biomaterials 1
Psychology, Mathematical 1
Rehabilitation 1
Evolutionary Biology 1
Endocrinology & Metabolism 1
Chemistry, Medicinal 1
Reproductive Biology 1
Cell & Tissue Engineering 1
Engineering, Biomedical 1
Geriatrics & Gerontology 1
Psychology, Experimental 1
Genetics & Heredity 1
Gastroenterology & Hepatology 1
Mathematical & Computational Biology 1
Biochemistry & Molecular Biology 1
Immunology 1
Environmental Sciences 1
Neurosciences 1
Public, Environmental & Occupational Health 1
Ecology 1
Economics 1
Education & Educational Research 1
Scopus #Pub
Cancer Research 18
Oncology 18
Medicine (All) 17
Radiology, Nuclear Medicine And Imaging 14
Public Health, Environmental And Occupational Health 6
Infectious Diseases 6
Surgery 3
Urology 2
Hematology 2
Pharmacology (Medical) 2
Obstetrics And Gynecology 2
Ceramics And Composites 1
Mechanics Of Materials 1
Pharmacology 1
Biomaterials 1
Genetics 1
Biophysics 1
Biochemistry 1
Molecular Medicine 1
Biochemistry, Genetics And Molecular Biology (All) 1
Physiology (Medical) 1
Pulmonary And Respiratory Medicine 1
Bioengineering 1
Immunology And Allergy 1
Drug Discovery 1
Agricultural And Biological Sciences (All) 1
SciELO #Pub
Health Sciences 30
Applied Social Sciences 1
Biological Sciences 1

Bases de Datos



Muestra la distribución de las publicaciones de la institución en las distintas bases de datos* (WoS, Scopus y SciELO-Chile).

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

* Una misma publicación puede pertenecer a más de una base de datos.

Base de Datos #Publicaciones
WOS 132
Scopus 158
SciELO 28

Autores



Nombre Género #Pub

Muestra un listado ordenado de los autores afiliados a la institución en publicaciones desde 2008.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.



Muestra la distribución de los autores de la institución por género.
Para determinar el género de cada nombre de autor, afiliado a una institución nacional, se realiza un trabajo automático de detección a partir de un diccionario de nombres en constante actualización, además del trabajo interno realizado en los datos de forma permanente.

Es importante mencionar que si no se encuentra el nombre del autor en el diccionario (que está en permanente actualización) este no se contabiliza y su género es Indeterminado.

Porcentaje Indeterminados: 23.6 % del total de autores de esta institutición.

Muestra la productividad, basada en cantidad de publicaciones, de los autores afiliados a la institución.

Colaboración Institucional



Muestra la distribución de la colaboración de las instituciones Chilenas por tipo, en publicaciones desde 2008 en adelante.
Los tipos de colaboración se definen de la siguiente forma:

  • Sin colaboración: publicaciones en las cuales sólo participa la institución.
  • Internacional: además de la institución, hay autores de instituciones extranjeras.
  • Nacional: además de la institución, hay autores de otras instituciones chilenas.
  • Mixta: además de la institución, hay autores de otras instituciones chilenas y además extranjeras.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Muestra el número de publicaciones por tipo de colaboración en cada año desde 2008.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Distribución del Impacto WoS



Publicaciones Citas
Total Porcentaje Total Porcentaje Representativas Cuartil (Mediana)
Q1 46 51.1 % 9302 94.9 % 31.0
Q2 16 17.8 % 316 3.2 % 12
Q3 9 10.0 % 116 1.2 % 6.0
Q4 19 21.1 % 68 0.7 % 3
Q1 Distribución disciplinas OECD / WoS
Q2 Distribución disciplinas OECD / WoS
Q3 Distribución disciplinas OECD / WoS
Q4 Distribución disciplinas OECD / WoS

Origen de Citas Identificadas



Muestra la distribución de países cuyos autores citan las publicaciones del Institución consultada.

Citas identificadas: Las citas provienen de documentos incluidos en la base de datos de DATACIENCIA

Citas Identificadas: 1.12 %
Citas No-identificadas: 98.88 %

Muestra la distribución de instituciones nacionales o extranjeras cuyos autores citan las publicaciones del Institución consultada.

Citas identificadas: Las citas provienen de documentos incluidos en la base de datos de DATACIENCIA

Citas Identificadas: 1.12 %
Citas No-identificadas: 98.88 %

Liderazgo



El liderazgo se define porque los autores pertenecientes a la Institución son primer autor o autor de correspondencia en las publicaciones con afiliación a esta institución.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Publicaciones



Título Año Citas
Unraveling Germline Predisposition In Hematological Neoplasms: Navigating Complexity In The Genomic Era 2024 0
Centralization And Automation Of Non Toxic Drug Reconstitution In The Pharmacy: A Strengths, Weaknesses, Opportunities, And Threats Analysis 2024 1
Decision Aids For People Facing Health Treatment Or Screening Decisions 2024 0
Imaging Gr Pr Expression In Metastatic Castration Resistant Prostate Cancer With [68 Ga]Ga Rm2—A Head To Head Pilot Comparison With [68 Ga]Ga Psma 11 2024 0
The Phenotypic Spectrum Of Spinocerebellar Ataxia Type 19 In A Series Of Latin American Patients 2024 0
Development Of Geriatric Oncology In Latin America: A Report From The Latin American Cooperative Oncology Group 2024 0
Porphyromonas Gingivalis, A Bridge Between Oral Health And Immune Evasion In Gastric Cancer 2024 0
Improved Overall Survival Of Transplant Eligible Newly Diagnosed Multiple Myeloma Patients In A Chilean Public Center. How Did We Achieve It? 2024 0
Overall Survival With Adjuvant Pembrolizumab In Renal Cell Carcinoma 2024 0
Variants In Brca1/2 In A Hospital Based Cohort In Chile And National Literature Review 2024 0
Early Detection And Diagnostic Approach Through Automated Hematological Analysis For Plasma Cell Leukemia 2024 0
Cpn Coverage Analysis: An R Package For Parameter Estimation In Conceptual Properties Norming Studies 2023 1
Prognostic Parameters On Baseline And Interim [<Sup>18</Sup>F]Fdg Pet/Computed Tomography In Diffuse Large B Cell Lymphoma Patients 2023 0
Primary Plasma Cell Leukemia In Latin America: Demographic, Clinical, And Prognostic Characteristics. A Study Of Gelamm Group 2023 2
First Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone For Metastatic Nsclc In Check Mate 9 La: 3 Year Clinical Update And Outcomes In Patients With Brain Metastases Or Select Somatic Mutations 2023 0
Consenso De La Sociedad Chilena De Infectología Para El Manejo De Episodios De Neutropenia Febril En Adultos Y Niños Con Cáncer 2023 0
Pazopanib In Locally Advanced Or Metastatic Renal Cell Carcinoma: Results Of A Randomized Phase Iii Trial 2023 1
Enhancing Equitable Access To Rare Disease Diagnosis And Treatment Around The World: A Review Of Evidence, Policies, And Challenges 2023 0
Factors Influencing The Implementation Of Shared Decision Making In Breast Cancer Care: Protocol For A Mixed Methods Study 2023 0
Minireview: Functional Roles Of Tissue Kallikrein, Kinins, And Kallikrein Related Peptidases In Lung Cancer 2023 0
Consensus Of The Chilean Society Of Infectious Diseases For The Management Of Episodes Of Febrile Neutropenia In Adults And Children With Cancer Consenso De La Sociedad Chilena De Infectología Para El Manejo De Episodios De Neutropenia Febril En Adultos Y Niños Con Cáncer 2023 0
Another Cause Of Pseudobasophilia: Flower Cells ( May 2023 , 10.1007/S12308 023 00548 5) 2023 0
A Plain Language Summary Of The Check Mate 649 Study: Nivolumab In Combination With Chemotherapy Compared To Chemotherapy Alone For Untreated Advanced Or Metastatic Cancer Of The Stomach Or Esophagus 2023 0
Cytoreductive Radical Prostatectomy Versus No Local Treatment In Patients With Metastatic Prostate Cancer 2023 0
Can We Predict Prostate Cancer Metastasis Based On Biomarkers? Where Are We Now? 2023 0
Another Cause Of Pseudobasophilia: Flower Cells 2023 1
Dabrafenib Plus Trametinib Versus Nivolumab For Advanced Melanoma 2023 0
Sentinel Lymph Node Biopsy Vs No Axillary Surgery In Patients With Small Breast Cancer And Negative Results On Ultrasonography Of Axillary Lymph Nodes The Sound Randomized Clinical Trial 2023 1
Perioperative Anaphylaxis Anafilaxia Perioperatoria 2023 0
Primary Bladder Sarcoma: A Multi Institutional Experience From The Rare Cancer Network 2023 0
First Graduate Of The Master Of Nursing In Advanced Practice In Oncology In Chile Primeira Graduada Do Mestrado Em Enfermagem Em Prática Avançada Em Oncologia No Chile Primera Graduada Del Magister En Enfermería De Práctica Avanzada En Oncología En Chile 2023 1
Viscoelastic Tests In The Perioperative Management Of Oncology Patients Pruebas Viscoelásticas En El Manejo Perioperatorio De Pacientes Oncológicos 2023 0
Oncoanesthesiology Is It A Necessary Subspeciality? ¿Es Necesaria Una Subespecialidad En Onco Anestesia? 2023 0
Abdominal Wall Blocks In Robotic Assisted Partial Nephrectomy Bloqueos De Pared Abdominal En Nefrectomía Parcial Asistida Por Robot 2023 0
Use Of 5 G Technology For Oncological Surgery Streaming Uso De Tecnología 5 G Para La Transmisión De Cirugías Oncológicas 2023 0
Update On The Diagnosis And Stratification Of Patients With Acute Myeloid Leukemia: An Urgent National Need 2023 0
Nivolumab Plus Docetaxel In Patients With Chemotherapy Nai Spacing Diaeresis Ve Metastatic Castration Resistant Prostate Cancer: Results From The Phase Ii Check Mate 9 Kd Trial 2022 19
First Line Nivolumab Plus Ipilimumab In Advanced Nsclc: 4 Year Outcomes From The Randomized, Open Label, Phase 3 Check Mate 227 Part 1 Trial 2022 122
Mutational Landscape And Actionable Target Rates On Advanced Stage Refractory Cancer Patients: A Multicenter Chilean Experience 2022 0
Nivolumab Plus Chemotherapy Or Ipilimumab In Gastro Oesophageal Cancer 2022 88
Water Based Acrylic Marker For Reflectance Confocal Microscopy Lesion Delineation 2022 0
Methods To Collect Communities' Values And Preferences About Health Systems Coverage 2022 0
A Simple Analytical Model For A Fast 3 D Assessment Of Peripheral Photon Dose During Coplanar Isocentric Photon Radiotherapy 2022 0
Survival And Response Deepening After Autologous Transplantation In Patients With Multiple Myeloma In Chile 2022 0
Evaluation Of The Health Technology Assessment Process Of The Financial Protection System For High Cost Diagnoses And Treatments In Chile (Ricarte Soto Law) 2022 1
Germline Pathogenic Variant Prevalence Among Latin American And Us Hispanic Individuals Undergoing Testing For Hereditary Breast And Ovarian Cancer: A Cross Sectional Study 2022 0
Complementary And Alternative Therapies In Skin Cancer A Literature Review Of Biologically Active Compounds 2022 0
Highlights Of The 'I Congress Ecancer Choosing Wisely' March 30 And 31, 2022 Santa Cruz, Bolivia 2022 0
Hemosiderotic Dermatofibroma: Clinical And Dermoscopic Presentation Of 5 Cases Dermatofibroma Hemosiderótico: Presentación Clínica Y Dermatoscópica De 5 Casos 2021 0
Accounting For Relatedness And Spatial Structure To Improve Plant Phenotypic Selection In The Wild 2021 0
Praxis Y Herramientas Del Psicólogo/A En Equipos Psicosociales Y Visita Domiciliaria Escolar: Nuevos Desafíos En Educación 2021 0
Diagnostic Accuracy Of <Sup>18</Sup>F Psma 1007 Pet/Ct Imaging For Lymph Node Staging Of Prostate Carcinoma In Primary And Biochemical Recurrence 2021 54
Modelling Cost Effectiveness Of Syphilis Detection Strategies In Prisoners: Exploratory Exercise In A Chilean Male Prison 2021 1
First Line Nivolumab Plus Ipilimumab Combined With Two Cycles Of Chemotherapy In Patients With Non Small Cell Lung Cancer (Check Mate 9 La): An International, Randomised, Open Label, Phase 3 Trial 2021 549
Insights Into Neutralizing Antibody Responses In Individuals Exposed To Sars Co V 2 In Chile 2021 21
First Line Nivolumab Plus Ipilimumab Versus Chemotherapy In Advanced Nsclc With 1% Or Greater Tumor Pd L1 Expression: Patient Reported Outcomes From Check Mate 227 Part 1 2021 28
Early Versus Deferred Anti Sars Co V 2 Convalescent Plasma In Patients Admitted For Covid 19: A Randomized Phase Ii Clinical Trial 2021 51
Frailty And Reduced Gait Speed Are Independently Related To Mortality Of Cirrhotic Patients In Long Term Follow Up 2021 11
Impact Of The Time Interval Between Primary Melanoma Excision And Sentinel Node Biopsy: A Systematic Review And Meta Analysis 2021 1
Coronary Ostia Localization By 3 Dimensional Transesophageal Echocardiography In A Patient With Quadricuspid Aortic Valve 2021 0
First Line Nivolumab Plus Chemotherapy Versus Chemotherapy Alone For Advanced Gastric, Gastro Oesophageal Junction, And Oesophageal Adenocarcinoma (Check Mate 649): A Randomised, Open Label, Phase 3 Trial 2021 832
A Randomized Clinical Trial To Assess The Effectiveness Of Pre And Post Surgical Pelvic Floor Physiotherapy For Bowel Symptoms, Pelvic Floor Function, And Quality Of Life Of Patients With Rectal Cancer: Carret Protocol 2021 4
A New Smoothened Antagonist Bearing The Purine Scaffold Shows Antitumour Activity In Vitro And In Vivo 2021 8
Update On Neuroendocrine Tumors 2021 0
Validation Of An Ngs Panel Designed For Detection Of Actionable Mutations In Tumors Common In Latin America 2021 2
Total Neoadjuvant Chemotherapy With Flot Scheme In Resectable Adenocarcinoma Of The Gastro Oesophageal Junction Or Gastric Adenocarcinoma: Impact On Pathological Complete Response And Safety 2021 4
Adjuvant Pembrolizumab After Nephrectomy In Renal Cell Carcinoma 2021 278
Can Kidney Parenchyma Metabolites Serve As Prognostic Biomarkers For Long Term Kidney Function After Nephrectomy For Renal Cell Carcinoma? A Preliminary Study 2021 1
Consensus For Treatment Of Metastatic Castration Sensitive Prostate Cancer: Report From The First Global Prostate Cancer Consensus Conference For Developing Countries (Pcccdc) 2021 6
Sin Ex Db 2.0 Update 2020: Database For Eukaryotic Single Exon Coding Sequences 2021 0
Temperature, But Not Excess Of Glycogen, Regulates "In Vitro" Ampk Activity In Muscle Samples Of Steer Carcasses 2021 4
Consensus On The Treatment And Follow Up For The Nonmetastatic Castration Resistant Prostate Cancer: A Report From The First Prostate Cancer Consensus Conference For Developing Countries 2021 3
Quality Improvement Initiative To Reduce Variability And Improve Stewardship Of Antimicrobial Prophylaxis For Transrectal Prostate Needle Biopsy 2020 3
Palmitic Acid Reduces The Autophagic Flux In Hypothalamic Neurons By Impairing Autophagosome Lysosome Fusion And Endolysosomal Dynamics 2020 20
Potential Use Of N 3 Puf As To Prevent Oxidative Stress Derived Ototoxicity Caused By Platinum Based Chemotherapy 2020 2
Caveolin 1 Mediated Tumor Suppression Is Linked To Reduced Hif1α S Nitrosylation And Transcriptional Activity In Hypoxia 2020 8
Management Plan For Breast Cancer During The Covid 19 Pandemic. A Single Institution Alternative To Treat Early Breast Cancer Patients In A Short Time 2020 2
Combined Visual And Semiquantitative Evaluation Improves Outcome Prediction By Early Midtreatment <Sup>18</Sup>F Fdg Pet In Diffuse Large B Cell Lymphoma 2020 6
Biochemical And Genomic Characterization Of The Cypermethrin Degrading And Biosurfactant Producing Bacterial Strains Isolated From Marine Sediments Of The Chilean Northern Patagonia 2020 10
Efficacy And Safety Of Dentoxol® In The Prevention Of Radiation Induced Oral Mucositis In Head And Neck Cancer Patients (Esdom): A Randomized, Multicenter, Double Blind, Placebo Controlled, Phase Ii Trial 2020 2
Identification Of A Patient Cohort With Relapsing Diffuse Large B Cell Lymphoma With A Low International Prognostic Index In Pet/Ct Using A 2 Gene (Lmo2/Tnfrsf9) Scoring System 2020 1
Cancer Immunotherapy: An Update Actualización General De Inmunoterapia En Cáncer 2020 3
Id1 And Pd 1 Combined Blockade Impairs Tumor Growth And Survival Of <I>Kras</I> Mutant Lung Cancer By Stimulating Pd L1 Expression And Tumor Infiltrating Cd8<Sup>+</Sup> T Cells 2020 5
Incidence Of Thyroid Cancer In An Oncological Clinic Of Santiago, Chile Epidemiología Del Cáncer De Tiroides En Un Instituto Oncológico. Efecto De Las Nuevas Recomendaciones Clínicas 2020 1
Efficacy And Safety Of Pembrolizumab Or Pembrolizumab Plus Chemotherapy Vs Chemotherapy Alone For Patients With First Line, Advanced Gastric Cancer: The Keynote 062 Phase 3 Randomized Clinical Trial 2020 472
Recommendations For Diagnosis And Pharmacological Management In Pediatric Patients With Sars Co V 2 (Covid 19) Infection 2020 0
Recommendations For The Study And Pharmacological Management In Adult Patients With Suspected Infection By Sars Co V 2 (Covid 19) 2020 0
Economic Evaluations Of Pharmacist Led Medication Review In Outpatients With Hypertension, Type 2 Diabetes Mellitus, And Dyslipidaemia: A Systematic Review 2019 8
Triple Negative Breast Cancer: The Reality In Chile And In Latin America 2019 7
Regional Differences In Gallbladder Cancer Pathogenesis: Insights From A Multi Institutional Comparison Of Tumor Mutations 2019 31
Prognostic Impact Of Renal Failure Recovery In Patients With Newly Diagnosed Multiple Mieloma 2019 0
Prognostic Impact Of Renal Failure Recovery In Patients With Newly Diagnosed Multiple Myeloma 2019 0
Real World Effectiveness And Tolerability Of Pazopanib As First Targeted Therapy In Metastatic Renal Cell Carcinoma: A Retrospective Chart Review In Latin America 2019 1
Nivolumab Plus Ipilimumab Versus Sunitinib In First Line Treatment For Advanced Renal Cell Carcinoma: Extended Follow Up Of Efficacy And Safety Results From A Randomised, Controlled, Phase 3 Trial 2019 483
The Challenge In Colistin Dosing: Updating Available Recommendations 2018 2
Survival Of 1,103 Chilean Patients With Multiple Myeloma Receiving Different Therapeutic Protocols From 2000 To 2016 2018 11
What Is The Evidence For The Clinical Value Of Sbrt In Cancer Of The Cervix? 2018 13
Nivolumab Plus Ipilimumab In Lung Cancer With A High Tumor Mutational Burden 2018 1551
Nivolumab Plus Ipilimumab Versus Sunitinib In Advanced Renal Cell Carcinoma 2018 2613
Tumor Lysate Based Vaccines: On The Road To Immunotherapy For Gallbladder Cancer 2018 31
Ver más publicaciones y descargar CSV

Listado ordenado de publicaciones desde 2008 y sus citas.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.


Descargar Descarga los datos de esta página (formato JSON).
Descargar Descarga los datos de esta página como un archivo Excel.